Stocktwits on MSN15h
Sarepta Therapeutics Temporarily Halts Three Clinical Studies Of Elevidys: Retail Is Dull While Stock Drops
Shares of Sarepta Therapeutics, Inc. (SRPT) traded over 2% lower in afternoon trade on Friday after the company said it has ...
Pharmaceutical Technology on MSN23h
NBE Therapeutics opens ADC research facility in Switzerland
NBE Therapeutics CEO Jean Engela stated: "This investment in a new, cutting-edge research centre underscores our strong ...
Council to consider proposal to be 'Blue Shield' city
City Council will act at a meeting Monday on a resolution that would designate Joplin as "Blue Shield City" for public safety. The action, along with some other steps, would make the city eligible for ...